Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1664-9. doi: 10.1136/jnnp.2005.070136.
J Neurol Neurosurg Psychiatry. 2005.
PMID: 16291891
Free PMC article.
Clinical Trial.